Related Experiment Video
Updated: Apr 6, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Admission Glucose Levels and the Risk of Acute Kidney Injury in Nondiabetic ST Segment Elevation Myocardial
Yacov Shacham1, Amir Gal-Oz2, Eran Leshem-Rubinow1
1Department of Cardiology, Tel Aviv Sourasky Medical Center Affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Insights
Severe hyperglycemia on admission increases acute kidney injury (AKI) risk in non-diabetic ST-elevation myocardial infarction (STEMI) patients. This finding highlights the importance of glucose control in STEMI patients without diabetes undergoing primary PCI.
Area of Science:
- Cardiology
- Nephrology
- Endocrinology
Background:
- Hyperglycemia at admission is linked to acute kidney injury (AKI) in ST-elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI).
- The association between hyperglycemia and AKI in STEMI patients without diabetes is less understood.
- This study investigates acute hyperglycemia's impact on AKI risk in nondiabetic STEMI patients treated with primary PCI.
Purpose of the Study:
- To evaluate the effect of admission hyperglycemia levels on the risk of AKI.
- To determine if severe hyperglycemia is an independent predictor of AKI in this specific patient group.
Main Methods:
- Retrospective analysis of 1,065 nondiabetic STEMI patients who underwent primary PCI.
- Stratification of patients into normal (<140 mg/dl), mild (140-200 mg/dl), and severe (>200 mg/dl) admission glucose groups.
- Review of medical records for AKI occurrence and serum creatinine changes.
Main Results:
- 38% of patients had hyperglycemia on admission.
- Severe admission hyperglycemia was associated with a significantly higher AKI rate (20% vs. 7-8%; p=0.001).
- Severe hyperglycemia independently predicted AKI (OR=2.46, p=0.018) and was linked to greater serum creatinine changes.
Conclusions:
- Severe admission hyperglycemia is an independent risk factor for AKI development.
- This risk is present in nondiabetic STEMI patients undergoing primary PCI.
- Admission glucose levels are crucial for assessing AKI risk in these patients.
Background:
Hyperglycemia upon admission is associated with an increased risk for acute kidney injury (AKI) in ST segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (PCI). However, the relation of this association to the absence of diabetes mellitus (DM) is less studied. We evaluated the effect of acute hyperglycemia levels on the risk of AKI among STEMI patients without DM who were all treated with primary PCI.
Methods:
We retrospectively studied 1,065 nondiabetic STEMI patients undergoing primary PCI. Patients were stratified according to admission glucose levels into normal (<140 mg/dl), mild (140-200 mg/dl), and severe (>200 mg/dl) hyperglycemia groups. Medical records were reviewed for the occurrence of AKI.
Results:
The mean age was 61 ± 13 years and 81% were males. Hyperglycemia upon hospital admission was present in 402 of 1,065 patients (38%). Patients with severe admission hyperglycemia had a significantly higher rate of AKI compared to patients with no or mild hyperglycemia (20 vs. 7 and 8%, respectively; p = 0.001) and had a significantly greater serum creatinine change throughout hospitalization (0.17 vs. 0.09 and 0.07 mg/dl, respectively; p = 0.04). In multivariate logistic regression, severe hyperglycemia emerged as an independent predictor of AKI (OR = 2.46, 95% CI 1.16-5.28; p = 0.018).
Conclusion:
Severe admission hyperglycemia is an independent risk factor for the development of AKI among nondiabetic STEMI patients undergoing primary PCI.
More Related Videos
18:11A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
Published on: December 28, 2012
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Kidney Injury I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations